Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

Abstract

Single courses of injection immunotherapy with Bet v 1 allergen derivatives showed trends towards improved well-being and reduced reactivity to specific allergen provocation, but did not yield significant improvement in the combined symptom medication score in this study.